blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3080258

EP3080258 - COMPOSITIONS AND METHODS OF USE OF CRISPR-CAS SYSTEMS IN NUCLEOTIDE REPEAT DISORDERS [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  21.02.2020
Database last updated on 30.10.2024
FormerExamination is in progress
Status updated on  26.05.2017
Most recent event   Tooltip21.02.2020Application deemed to be withdrawnpublished on 25.03.2020  [2020/13]
Applicant(s)For all designated states
The Broad Institute, Inc.
415 Main Street
Cambridge, MA 02142 / US
For all designated states
Massachusetts Institute of Technology
77 Massachusetts Avenue
Cambridge, MA 02139 / US
For all designated states
University of Iowa Research Foundation
112 N. Capitol Street
6 Gilmore Hall
Iowa City, Iowa 52242-5500 / US
[2019/38]
Former [2016/42]For all designated states
The Broad Institute, Inc.
415 Main Street
Cambridge, MA 02142 / US
For all designated states
Massachusetts Institute of Technology
77 Massachusetts Avenue
Cambridge, MA 02142 / US
For all designated states
University of Iowa Research Foundation
112 N. Capitol Street
6 Gilmore Hall
Iowa City, Iowa 52242-5500 / US
Inventor(s)01 / DAVIDSON, Beverly
c/o University Of Iowa Research Foundation
112 N. Capitol Street
6 Gilmore Hall
Iowa City, IA 52242-5500 / US
02 / LIN, Chie-yu
30 Clarendon Street
Boston, MA 02116 / US
03 / RODRIGUEZ, Edgardo
c/o University Of Florida
1275 Center Drive
Bms J-487
P.O. Box 100159
Gainesville, FL 32610 / US
04 / ZHANG, Feng
100 Pacific Street
Apt. 11
Cambridge, MA 02139 / US
 [2016/42]
Representative(s)V.O.
P.O. Box 87930
Carnegieplein 5
2508 DH Den Haag / NL
[2016/42]
Application number, filing date14821430.712.12.2014
[2016/42]
WO2014US69902
Priority number, dateUS201361915150P12.12.2013         Original published format: US 201361915150 P
US201462010879P11.06.2014         Original published format: US 201462010879 P
US201462010888P11.06.2014         Original published format: US 201462010888 P
[2016/42]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2015089354
Date:18.06.2015
Language:EN
[2015/24]
Type: A1 Application with search report 
No.:EP3080258
Date:19.10.2016
Language:EN
The application published by WIPO in one of the EPO official languages on 18.06.2015 takes the place of the publication of the European patent application.
[2016/42]
Search report(s)International search report - published on:EP18.06.2015
ClassificationIPC:C12N9/22, C12N15/10, C12N15/85
[2016/42]
CPC:
C12N9/22 (EP,IL,KR,US); A01K67/0276 (EP,IL,KR,US); C12N15/63 (EP,IL,KR,US);
A61K31/713 (EP,IL,US); A61K38/465 (EP,IL,US); A61K48/005 (IL,US);
A61P21/02 (EP,IL); A61P21/04 (EP,IL); A61P25/00 (EP,IL);
A61P25/14 (EP,IL); A61P25/28 (EP,IL); B82Y5/00 (EP,IL,KR,US);
C12N15/102 (EP,IL,KR,US); C12N15/1082 (EP,IL,KR,US); C12N15/113 (IL,US);
C12N15/86 (IL,US); C12N15/907 (EP,IL,KR,US); C12N7/00 (IL,US);
C12Y301/00 (EP,IL,US); A01K2217/075 (EP,IL,KR,US); A01K2227/105 (EP,IL,KR,US);
A01K2267/0318 (EP,IL,KR,US); C12N2740/15043 (IL,US); C12N2750/14143 (EP,IL,KR,US);
Y02A50/30 (EP) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2016/42]
TitleGerman:ZUSAMMENSETZUNGEN UND VERFAHREN ZUR VERWENDUNG VON CRISPR-CAS-SYSTEMEN BEI NUKLEOTID-REPEAT-ERKRANKUNGEN[2016/42]
English:COMPOSITIONS AND METHODS OF USE OF CRISPR-CAS SYSTEMS IN NUCLEOTIDE REPEAT DISORDERS[2016/42]
French:COMPOSITIONS ET PROCÉDÉS D'UTILISATION DE SYSTÈMES CRISPR-CAS DANS LES MALADIES DUES À UNE RÉPÉTITION DE NUCLÉOTIDES[2016/42]
Entry into regional phase24.06.2016National basic fee paid 
24.06.2016Designation fee(s) paid 
24.06.2016Examination fee paid 
Examination procedure24.06.2016Examination requested  [2016/42]
18.01.2017Amendment by applicant (claims and/or description)
24.05.2017Despatch of a communication from the examining division (Time limit: M06)
04.12.2017Reply to a communication from the examining division
31.01.2018Despatch of a communication from the examining division (Time limit: M06)
09.08.2018Reply to a communication from the examining division
17.09.2018Despatch of a communication from the examining division (Time limit: M06)
26.03.2019Reply to a communication from the examining division
10.04.2019Despatch of a communication from the examining division (Time limit: M06)
22.10.2019Application deemed to be withdrawn, date of legal effect  [2020/13]
18.11.2019Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2020/13]
Divisional application(s)EP19204059.0
Fees paidRenewal fee
27.12.2016Renewal fee patent year 03
27.12.2017Renewal fee patent year 04
31.12.2018Renewal fee patent year 05
27.12.2019Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[I]US2011016540  (WEINSTEIN EDWARD [US], et al);
 [X]WO2013130824  (SANGAMO BIOSCIENCES INC [US]);
 [X]WO2013176772  (UNIV CALIFORNIA [US], et al);
 [XP]WO2014093622  (BROAD INST INC [US], et al);
 [E]WO2014204729  (BROAD INST INC [US], et al);
by applicantEP0264166
 US4873316
 US5543158
 US5580859
 WO9639154
 US5589466
 US5593972
 WO9703211
 US5846946
 US5855913
 US5985309
 US6007845
 US2004013648
 US6750059
 US2004171156
 US2005019923
 EP1519714
 EP1664316
 US2006281180
 US2007025970
 US2007054961
 EP1766035
 EP1781593
 US7259015
 US7303910
 US7351585
 US2008267903
 US2009007284
 US2009017543
 US2009111106
 US7745651
 US7776321
 US7799565
 US7803397
 US7838658
 US2010317109
 US2011016540
 US7901708
 WO2011028929
 US2011059502
 US7915399
 US2011117189
 US7982027
 US2011195123
 US8058069
 US2011293571
 US2011293703
 US8101741
 US8188263
 US8236943
 WO2012135025
 US2012251560
 US2012251618
 US8283333
 US2012295960
 US8404658
 US8454972
 US2013245107
 US2013244279
 US2013253040
 US2013252281
 US2013302401
 WO2014018423
 US8697359
 US8709843
 US2014170753
 WO2014093661
 WO2014093694
 WO2014093595
 WO2014093718
 WO2014093709
 WO2014093622
 WO2014093635
 WO2014093655
 WO2014093712
 WO2014093701
 US2014179770
 US2014179006
 US2014189896
 US2014186958
 US2014186919
 US2014186843
 US8771945
 US8795965
 EP2764103
 US2014227787
 US2014234972
 US2014242700
 US2014242699
 US2014242664
 EP2771468
 US2014248702
 US2014256046
 US2014273234
 US2014273232
 US2014273231
 US2014287938
 EP2784162
 US2014310830
 US8865406
 US8871445
 US8889356
 US8889418
 US8895308
 US20040491026
 US20090511940
 WO2014US41803
 WO2014US41800
 WO2014US41804
 WO2014US41806
 WO2014US41809
 WO2014US41808
 WO2014US62558
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.